More than 8 million Americans aged 40 and over have peripheral arterial disease (PAD), according to the National Heart. Lung and Blood Institute. Biomedical researchers define PAD as a reduction in blood flow in the vessels that carry blood from the heart to other parts of the body, which can lead to poor circulation in the long run.
Dr. Michael R. Jaff, an expert in vascular diseases such as stroke, PAD and deep vein thrombosis, is vice president of clinical affairs, innovation, technology and peripheral interventions at Boston Scientific. .
He will speak about blocked arteries and the pandemic at Healthy Doses, a health and wellness event to be held Friday, October 1 at the Boston Science Auditorium at La Familia Wellness Center in STEM City USA.
Save the date: Friday, October 1 from 9:00 a.m. to 12:00 p.m. EDT. Click here to register now.
Dr Jaff has published extensively in vascular medicine with over 300 peer-reviewed publications and ten textbooks. Professor of Medicine at Harvard Medical School (currently on leave of absence), he served as President of Newton-Wellesley Hospital from 2016 to 2019. Prior to that, he was Paul and Phyllis Fireman Endowed Chair of Vascular Medicine and Medical Director of the Fireman Vascular Center at Massachusetts General Hospital.
Jaff is the founder of VasCore, the largest Vascular Ultrasound Core Laboratory in the United States. VasCore has participated in the assay design and analysis of vascular laboratory images for more than 200 prospective multicenter trials of peripheral vascular and pharmaceutical devices in 66 countries.
He is a past president of the Society for Vascular Medicine and Biology and was the first physician to be awarded the title of master of the Society for Vascular Medicine. He is a fellow of the American College of Physicians, the American College of Cardiology, the American Heart Association, and the Society for Cardiovascular Angiography and Intervention. In addition, he is a certified vascular interpreter.
Click here to register now.